ZA989356B - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
ZA989356B
ZA989356B ZA989356A ZA989356A ZA989356B ZA 989356 B ZA989356 B ZA 989356B ZA 989356 A ZA989356 A ZA 989356A ZA 989356 A ZA989356 A ZA 989356A ZA 989356 B ZA989356 B ZA 989356B
Authority
ZA
South Africa
Prior art keywords
pentaerythritol
pharmaceutical preparations
dinatrate
pentaerythrito
petn
Prior art date
Application number
ZA989356A
Other languages
English (en)
Inventor
Ulrich Guenther Ulrike Kuntze
Wilhelm Thomas Lehr Freita Nat
Original Assignee
Isis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharma Gmbh filed Critical Isis Pharma Gmbh
Publication of ZA989356B publication Critical patent/ZA989356B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA989356A 1997-10-16 1998-10-14 Pharmaceutical preparations ZA989356B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745618 1997-10-16

Publications (1)

Publication Number Publication Date
ZA989356B true ZA989356B (en) 1998-11-16

Family

ID=7845649

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989356A ZA989356B (en) 1997-10-16 1998-10-14 Pharmaceutical preparations

Country Status (12)

Country Link
EP (1) EP1023059B1 (cs)
AT (1) ATE313323T1 (cs)
AU (1) AU1660399A (cs)
CZ (1) CZ301265B6 (cs)
DE (3) DE59813300D1 (cs)
DK (1) DK1023059T3 (cs)
ES (1) ES2255193T3 (cs)
HU (1) HUP0100634A3 (cs)
PL (1) PL340386A1 (cs)
SK (1) SK284769B6 (cs)
WO (1) WO1999018930A2 (cs)
ZA (1) ZA989356B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087926A2 (de) * 1998-06-24 2001-04-04 Alpharma-Isis GmbH & Co. KG Analytische substrate und antioxidative mittel
DE102008050597A1 (de) 2008-10-09 2010-04-15 Actavis Deutschland Gmbh & Co. Kg Pharmazeutische Zubereitungen zur Anwendung in einem Verfahren zur therapeutischen Behandlung von Hörsturz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
ATE49503T1 (de) * 1982-09-29 1990-02-15 Ici America Inc Organische nitrate enthaltende arzneimischungen, die gegen detonation durch feuer stabil sind.
DE3328094A1 (de) * 1983-08-04 1985-02-21 H. Trommsdorff GmbH & Co, 5110 Alsdorf Phlegmatisierte pharmazeutische zubereitung von explosionsfaehigen salpetersaeureestern
WO1990009171A1 (fr) * 1989-02-20 1990-08-23 Soorianarain Baligadoo Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen

Also Published As

Publication number Publication date
EP1023059A2 (de) 2000-08-02
DK1023059T3 (da) 2006-04-24
AU1660399A (en) 1999-05-03
WO1999018930A3 (de) 1999-10-07
HUP0100634A2 (hu) 2001-07-30
SK284769B6 (sk) 2005-11-03
WO1999018930A2 (de) 1999-04-22
SK5382000A3 (en) 2000-11-07
ES2255193T3 (es) 2006-06-16
EP1023059B1 (de) 2005-12-21
CZ301265B6 (cs) 2009-12-23
HUP0100634A3 (en) 2003-07-28
DE59813300D1 (de) 2006-01-26
DE29880094U1 (de) 2000-05-18
ATE313323T1 (de) 2006-01-15
DE19847781A1 (de) 1999-04-22
CZ20001342A3 (cs) 2000-09-13
PL340386A1 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
CA2170255A1 (en) Pharmaceutical Composition for Immunoenhancement Therapy
MX9505182A (es) Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p.
IL92007A0 (en) Pharmaceutical compositions containing gestodene
DK65293D0 (da) Fremgangsmaade til administrering af taxol
TR199802423T2 (xx) Konsantre antikor terkibi.
MY118392A (en) Variable day start tablet dispenser
AU1890295A (en) Piperidines and pyrrolidines
TW261615B (cs)
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
YU52999A (sh) Kombinacija analgetika
EP0663835A1 (en) USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS.
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
IL138634A (en) Use of lasofoxifene for the prepartion of single dose medicament
ZA989356B (en) Pharmaceutical preparations
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.
CO4940457A1 (es) Composiciones farmaceuticas que comprenden sensibilizadores a insulina para tratamiento de la diabetes
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
BR9714945A (pt) Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
AU6404798A (en) Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa